GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » Shares Buyback Ratio %

Genix Pharmaceuticals (TSXV:GENX) Shares Buyback Ratio % : 0.00 (As of Apr. 13, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Genix Pharmaceuticals Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Genix Pharmaceuticals's current shares buyback ratio was 0.00%.


Genix Pharmaceuticals Shares Buyback Ratio % Historical Data

The historical data trend for Genix Pharmaceuticals's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genix Pharmaceuticals Shares Buyback Ratio % Chart

Genix Pharmaceuticals Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -57.87 - - - -

Genix Pharmaceuticals Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genix Pharmaceuticals Shares Buyback Ratio % Calculation

Genix Pharmaceuticals's Shares Buyback Ratio for the fiscal year that ended in Oct. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Oct. 2023 ) - Shares Outstanding (EOP) (A: Oct. 2024 )) / Shares Outstanding (EOP) (A: Oct. 2023 )
=(59.224 - 59.224) / 59.224
=0.00%

Genix Pharmaceuticals's Shares Buyback Ratio for the quarter that ended in Jan. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Oct. 2024 ) - Shares Outstanding (EOP) (A: Jan. 2025 )) / Shares Outstanding (EOP) (A: Oct. 2024 )
=(59.224 - 59.224) / 59.224
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genix Pharmaceuticals Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genix Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically, the company operates only in Canada.
Executives
Sina Pirooz Director
Paul Chow 10% Security Holder, Director
Jamie A. Lewin Director

Genix Pharmaceuticals Headlines

No Headlines